Therapeutic drug monitoring of dolutegravir in children and adolescents living with HIV: A retrospective study

Documenti analoghi

• Clinical outcomes of switching to dolutegravir/lamivudine dual therapy in people living with HIV: A single‐centre retrospective study
  di: D. Yagci‐Caglayik, et al.
  Pubblicazione: (2025)
• Therapeutic drug monitoring—Does it really matter?
  di: Hans Lennernäs, et al.
  Pubblicazione: (2024)
• Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study
  di: Gianluca Gazzaniga, et al.
  Pubblicazione: (2026)
• A preliminary analysis of the impact of pharmacogenetic variation on bictegravir and dolutegravir concentrations in individuals with HIV and tuberculosis
  di: A. Naidoo, et al.
  Pubblicazione: (2025)
• A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates
  di: Mehdi El Hassani, et al.
  Pubblicazione: (2024)